The pharmaceutical and life sciences industries are investing in stem cells, either in direct applications where the stem cells themselves would be used for therapy or indirectly, where stem cell derived tissues will be used for drug screening and toxicity testing. This programme is intended to meet current and future needs of the pharmaceutical industry and health care providers by providing a cadre of well-trained scientists capable of fulfilling managerial, administrative, research and technical roles within the developing commercial regenerative medicine sector.

Graduates will be equipped for a variety of roles within the developing commercial regenerative medicine sector.